Gilead names Daniel O’Day CEO Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its Board of Directors has named Daniel O’Day Chairman of the Board and Chief Executive Officer, effective March 1, 2019. Mr. O’Day … more ➔
Genentech CEO to switch to Roche Pharma William Anderson, currently CEO of Genentech, will be appointed CEO Roche Pharmaceuticals effective 1 January 2019. He will be based in Basel, report to Severin Schwan, Roche Group CEO and become a … more ➔
Forbion appoints Dr. Carlo Incerti as Operating Partner Forbion, a European life science venture capital firm, today announces that Carlo Incerti, M.D., will be joining Forbion as Operating Partner, effective 1st January 2019. more ➔
Merck appoints Jasper Bos as Managing Director of M Ventures Merck today announced the appointment of Jasper Bos as the new Managing Director of its strategic corporate venture capital arm M Ventures. more ➔
Bergenbio appoints Alan Barge MD as interim CMO Bergenbio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, oral, selective AXL kinase inhibitors for multiple cancer indications, has announced the appointment of Alan … more ➔
Hox Therapeutics appoints Karl Keegan as CEOHox Therapeutics has announced the appointment of Dr Karl Keegan as Chief Executive Officer. more ➔
Adrienne Graves joins Oxurion’s BoardOxurion NV (formerly known as ThromboGenics NV), a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye, announced today the appointment … more ➔
Zelluna appoints new CFOZelluna Immunotherapy has announced the appointment of Geir Christian Melen as chief financial officer (CFO). more ➔
Aglaris Appoints New CEOAglaris Ltd. yesterday announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately. more ➔
Exscientia Appoints Georgy Egorov as CFOExscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO). more ➔
